Testing a device to automatically track urine and stool output in hospitalized patients
Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
This study is testing a new toilet device that automatically tracks urine and stool output for patients in the hospital to see if it provides accurate information during their treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 54 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT05520346 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate a prototype toilet device designed to automatically and accurately track fluid output from patients undergoing hematopoietic stem cell transplants. Participants will use the device in their hospital rooms during their inpatient stay, with fluid output measured both automatically by the device and manually by nursing staff at different times. The goal is to assess the device's effectiveness in providing reliable data on renal and gastrointestinal fluid output.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 scheduled for hematopoietic stem cell transplants with a Karnofsky Performance Scale score of 70 or higher.
Not a fit: Patients who cannot use a standard toilet due to physical constraints or those advised against using the device by their physician may not benefit from this study.
Why it matters
Potential benefit: If successful, this device could enhance patient monitoring and improve clinical decision-making by providing accurate fluid output data.
How similar studies have performed: While the specific approach of this device is novel, similar studies have shown promise in improving patient monitoring through automated systems.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic * Age 18-80 years * Karnofsky Performance Scale KPS ≥ 70 * Able to read/write English Exclusion Criteria: * Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter * Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning
Where this trial is running
Durham, North Carolina
- Duke University — Durham, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Chenyu Lin, MD — Duke University
- Study coordinator: Lauren Hill
- Email: lauren.hill@duke.edu
- Phone: 919-668-2369
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.